Literatur
- 1
Alings M, Wilde A.
„Brugada syndrome”.
Clinical data and suggested pathophysiological mechanism.
Circulation.
1999;
99
666-673
- 2
Antzelevitch C.
The
Brugada syndrome: diagnostic criteria and cellular mechanisms.
Eur
Heart J.
2001;
22
356-363
- 3
Bermudez E P, Garcia-Alberola A, Sanchez J M, Sanchez Munoz J J, Chavarri M V.
Spontaneous sustained
monomorphic ventricular tachycardia after administration of ajmaline
in a patient with Brugada syndrome.
Pacing Clin Electrophysiol.
2000;
23
407-409
- 4
Bezzina C, Veldkamp M W, Van den Berg M P. et al .
A single Na+-channel
mutation causing both long-QT and Brugada syndromes.
Circ
Res.
1999;
85
1206-1213
- 5
Bianco M, Bria S, Gianfelici A, Sanna N, Palmieri V, Zepilli P.
Does early repolarization
in the athlete have analogies with the Brugada syndrome?.
Eur
Heart J.
2001;
22
504-510
- 6
Brugada J, Brugada R, Antzelevitch C, Towbin J, Nadamanee K, Brugada P.
Long-term follow-up
of individuals with the electrocardiographic pattern of right bundle-branch
block and ST-segment elevation in precordial leads V1 to V3.
Circulation.
2002;
105
73-78
- 7
Brugada P, Brugada J.
Right bundle branch
block, persistent ST segment elevation and sudden cardiac death:
a distinct clinical and electrocardiographic syndrome.
J
Am Coll Cardiol.
1992;
20
1391-1396
- 8
Brugada P, Brugada R, Brugada J.
Letters
to the editor - A reply.
Eur Heart J.
2000;
21
1482-1485
- 9
Brugada R, Brugada J, Antzelevitch C. et al .
Sodium channel blockers identify risk for
sudden death in patients with ST-segment elevation and right bundle branch
block but structurally normal hearts.
Circulation.
2000;
101
510-515
- 10
Camm A J, Janse M J, Roden D M, Rosen M R, Cinca J, Cobbe S M.
Congenital
and acquired long QT syndrome.
Eur Heart J.
2000;
21
1232-1237
- 11
Chen Q, Kirsch G E, Zhang D. et al .
Genetic basis and molecular mechanism for idiopathic
ventricular fibrillation.
Nature.
1998;
392
293-296
- 12
Compton S J, Lux R L, Ramsey M R. et al .
Genetically defined therapy
of inherited long-QT syndrome. Correction of abnormal repolarization
by potassium.
Circulation.
1996;
94
1018-1022
- 13
Consensus Statement of the
Joint Steering Committees of the Unexplained Cardiac Arrest Registry
of Europe and of the Idiopathic Ventricular Fibrillation Registry
of the United States .
Survivors of out-of-hospital
cardiac arrest with apparently normal heart. Need for definition
and standardized clinical evaluation.
Circulation.
1997;
95
265-272
- 14
Corrado D, Basso C, Buja G, Nava A, Rossi L, Thiene G.
Right bundle branch block, right precordial
ST-segment elevation, and sudden death in young people.
Circulation.
2001;
103
710-717
- 15
Dorostkar P C, Eldar M, Belhassen B, Scheinman M M.
Long-term
follow-up of patients with long-QT syndrome treated with β-blockers
and continous pacing.
Circulation.
1999;
100
2431-2436
- 16
Gussak I, Antzelevitch C, Bjerregaard P, Towbin J A, Chaitman B R.
The Brugada syndrome: clinical, electrophysiologic
and genetic aspects.
J Am Coll Cardiol.
1999;
33
5-15
- 17
Haissaguerre M, Shah D C, Jais P. et al .
Role of Purkinje conducting system in triggering
of idiopathic ventricular fibrillation.
Lancet.
2002;
359
677-678
- 18
Haverkamp W, Breithardt G, Camm A J. et al .
The potential for QT prolongation and proarrhythmia
by non-antiarrhythmic drugs: clinical and regulatory implications.
Report on a policy conference of the European Society of Cardiology.
Eur
Heart J.
2000;
21
1216-1231
- 19
Hermida J S, Lemoine J L, Aoun F B, Jarry G, Rey J L, Quiret J C.
Prevalence
of the Brugada syndrome in an apparently healthy population.
Am
J Cardiol.
2000;
86
91-94
- 20
Hohnloser S H, Andresen D, Block M. et al .
Leitlinien zur Implantation von Defibrillatoren.
Z
Kardiol.
2000;
89
126-135
- 21
Khan I A.
Clinical
and therapeutic aspects of congenital and acquired long QT syndrome.
Am
J Med.
2002;
112
58-66
- 22
Kimbrough J, Moss A J, Zareba W. et al .
Clinical implications for affected parents
and siblings of probands with long-QT syndrome.
Circulation.
2001;
104
557-562
- 23
Kyndt F, Probst V, Potet F. et
al .
Novel SCN5A mutation leading either to isolated cardiac
conduction defect or Brugada syndrome in a large french family.
Circulation.
2001;
104
3081-3086
- 24
Leenhardt A, Glaser E, Burguera M, Nürnberg M, Maison-Blanche P, Coumel P.
Short-coupled
variant of torsade de pointes. A new electrocardiographic entity in
the spectrum of idiopathic ventricular tachyarrhythmias.
Circulation.
1994;
89
206-215
- 25
Leenhardt A, Lucet V, Denjoy I. et al .
Catecholaminergic polymorphic ventricular tachycardia
in children: a 7-year follow-up of 21 patients.
Circulation.
1995;
91
1512-1519
- 26
Monroe M H, Littmann l.
Two-year case collection
of the Brugada syndrome electrocardiogram pattern in a large teaching
hospital.
Clin Cardiol.
2000;
23
849-851
- 27
Moss A J, Zareba W, Hall W J. et al .
Effectiveness and limitations of β-blocker
therapy in congenital long-QT syndrome.
Circulation.
2000;
101
616-623
- 28
Nademanee K, Veerakul G, Nimmannit S. et al .
Arrhythmogenic marker for the sudden unexplained
death syndrome in Thai men.
Circulation.
1997;
96
2595-2600
- 29
Priori S G, Aliot E, Blomstrom-Lundqvist C. et al .
Task force on sudden cardiac death of the
European Society of Cardiology.
Eur Heart J.
2001;
22
1374-1450
- 30
Priori S G, Borggrefe M, Camm A J. et al .
Role of the implantable cardioverter defibrillator
in patients with idiopathic ventricular fibrillation. Data from
the UCARE international registry.
Pacing Clin Electrophysiol.
2001;
18
799
- 31
Priori S G, Napolitano C, Gasparini M. et al .
Natural history of Brugada syndrome. Insights
for risk stratification and management.
Circulation.
2002;
105
1342-1347
- 32
Priori S G, Napolitano C, Grillo M.
Concealed
arrhythmogenic syndromes: the hidden substrate of idiopathic ventricular
fibrillation?.
Cardiovasc Res.
2001;
50
218-223
- 33
Priori S G, Napolitano C, Tiso N. et al .
Mutations in the cardiac ryanodine receptor gene
(hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia.
Circulation.
2001;
103
196-200
- 34
Remme C A, Wever E FD, Wilde A AM, Derksen R, Hauer R W.
Diagnosis and long-term follow-up
of the Brugada syndrome in patients with idiopathic ventricular fibrillation.
Eur
Heart J.
2001;
22
400-409
- 35
Roden D M.
Pharmacogenetics
and drug-induced arrhythmias.
Cardiovasc Res.
2001;
50
224-231
- 36
Schwartz P J.
Idiopathic
long-QT syndrome: progress and questions.
Am Heart J.
1985;
2
399-411
- 37
Schwartz P J, Locati E H, Moss A J, Crampton R S, Trazzi R, Ruberti U.
Left
cardiac sympathetic denervation in the therapy of congenital long
QT syndrome.
Circulation.
1991;
84
503-511
- 38
Schwartz P J, Moss A J, Vincent G M, Crampton R S.
Diagnostic
criteria for the long QT syndrome. An update.
Circulation.
1993;
88
782-784
- 39
Schwartz P J, Priori S G, Locati E H. et al .
Long QT syndrome patients
with mutations of the SCN5A and HERG genes have differential responses
to Na+ channel blockade and to increases in heart rate:
implications for gene-specific therapy.
Circulation.
1995;
92
3381-3386
- 40
Schwartz P J, Priori S G, Spazzolini C. et al .
Genotype-phenotype correlation in the long-QT
syndrome.
Circulation.
2001;
103
89-95
- 41
Splawski I, Shen J, Timothy K W. et al .
Spectrum of mutations in long-QT syndrome
genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2.
Circulation.
2000;
102
1178-1185
- 42
Tan H L, Bink-Boelkens M TE, Bezzina C R.
A sodium-channel mutation causes isolated
cardiac conduction disease.
Nature.
2001;
409
1043-1047
- 43
Viskin S, Belhassen B.
Polymorphic ventricular
tachyarrhythmias in the absence of organic heart disease: classification,
differential diagnosis, and implications for therapy.
Prog
Cardiovasc Dis.
1998;
41
17-34
- 44
Viskin S, Fish R, Eldar M. et
al .
Prevalence of the Brugada sign in idiopathic ventricular
fibrillation and healthy controls.
Heart.
2000;
84
31-33
- 45
Yan G X, Antzelevitch C.
Cellular basis
for the Brugada syndrome and other mechanisms of arrhythmogenesis
associated with ST-segment elevation.
Circulation.
1999;
100
1660-1666
- 46
Zareba W, Moss A J, Schwartz P J. et al .
Influence of the genotype
on the clinical course of the long-QT syndrome.
New Engl
J Med.
1998;
339
965-960
Dr. Axel Buob
Medizinische Universitätsklinik und Poliklinik, Innere
Medizin III, Universitätskliniken des Saarlandes
66421 Homburg/Saar
Phone: 06841/1623372
Fax: 06841/1623394
